Vital Sign Monitoring Devices:
The vital signs monitor is a useful device, which helps in informing the medical and nursing personnel about the patient's physiologic status. It generally includes a collection of modules for the real-time monitoring of several physiological parameters. The term "patient monitors" is also used for these monitors. Electrocardiogram (ECG) and heart rate, pulse oxygen saturation (SpO2) and pulse rate, respiration rate, body temperature, and non-invasive and invasive blood pressure (BP) are the five-parameter modules that are most frequently monitored and suggested. An irregular respiratory rate is a vital sign of severe disease and is used to track the evolution of illnesses.
A few significant drivers of the market's expansion are the rising need for healthcare that is tailored to each patient's needs, the rising use of medical insurance, expanding product innovation, and rising consumer demand for domestic healthcare services. Additionally, the market for vital sign monitoring devices will rise because of an increase in the elderly population and better reimbursement policies for monitoring equipment.
Market Dynamic of Vital Sign Monitoring Devices Market
Drivers:
Increasing need for chronic disease/ Noncommunicable diseases (NCDs) patient monitoring:
The increasing need for monitoring patients with chronic illnesses is the main factor driving the global market for vital signs monitoring devices. Complications are more likely to occur in patients with chronic diseases. Healthcare workers can act early and stop future difficulties by using vital sign monitoring equipment to identify early warning indications of complications, such as changes in blood pressure or heart rate. Additionally, by delivering real-time information on a patient's vital signs, vital sign monitoring devices help patients better manage their chronic diseases.
According to WHO, Chronic diseases/ noncommunicable diseases (NCDs) account for 41 million annual fatalities or 74% of all fatalities worldwide. The majority of NCDs, or 17.9 million fatalities per year, are caused by cardiovascular illnesses, followed by malignancies (9.3 million), chronic respiratory conditions (4.1 million), and diabetes (2.0 million, including deaths from renal disease brought on by diabetes).
Continuous Innovation for the Development of New Products:
Different monitoring devices once measured blood pressure (BP), pulse rate, and body temperature separately. Now, a single vital sign monitoring system monitors all three parameters. The need for precise diagnoses and the general lack of nursing services have fueled ongoing innovation in the field of vital sign monitoring devices. The imbalance between the growing need for ongoing medical monitoring and a lack of qualified practitioners creates a favorable environment for innovation in vital sign monitoring technology.
The need for new items, such the digital thermometer or wireless monitoring devices, has grown, which has also raised sales of these products. There are active innovation ecosystems in the sensor and microelectronic technology fields trying to enhance precision, sensitivity, multi-parametric sensing, and wireless monitoring. The market for devices that monitor vital signs is directly impacted by these advancements.
Restraints:
Challenges associated with monitoring devices:
There are certain disadvantages to remote patient monitoring, such as its reliance on expensive technology that only a few patients can afford.
Systems using RPM require dependable internet connectivity. Some patients may lack broadband connection, which makes it more challenging for them to take part in RPM arrangements. In some cases, inappropriate usage might compromise the accuracy of patient data acquired. This is particularly true for several wearable devices used in healthcare. Only the most reliable firms should supply the data. One example is that simple fitness-tracking devices have error margins of up to 25%.
Recent Development:
March 2022
BioIntelliSense Launched New BioButton Rechargeable Wearable Device. The new BioButton Rechargeable device allows for continuous multi-parameter monitoring of a broad range of 20+ vital signs and physiologic biometrics for up to 30 days on a single charge.
Conclusion:
A few significant drivers of the market's expansion are the rising need for healthcare that is tailored to each patient's needs, the rising use of medical insurance, expanding product innovation, and rising consumer demand for domestic healthcare services. Additionally, the market for vital sign monitoring devices will rise because of an increase in the elderly population and better reimbursement policies for monitoring equipment.
Author's Detail:
Anushka Gore /
LinkedIn